These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2652819)

  • 1. Multiple injections of KCl-extracted donor-antigen in combination with a short course of cyclosporine therapy induces prolonged heart allograft survival in rats.
    Goto S; Stepkowski SM; Kahan BD
    Transplant Proc; 1989 Apr; 21(2):3300-2. PubMed ID: 2652819
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefit of multiple over single doses of 3M KCL-extracted histocompatibility antigen in the potentiating cyclosporine-induced prolongation of rat cardiac allograft survival.
    Goto S; Stepkowski SM; Kahan BD
    Transplantation; 1992 Mar; 53(3):705-7. PubMed ID: 1549876
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of FK 506 and cyclosporine on heart allograft survival in rats.
    Goto S; Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):529-30. PubMed ID: 1703700
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of unresponsiveness after local low-dose cyclosporine administration.
    Stepkowski S; Goto S; Reynolds K; Ito T; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1120-2. PubMed ID: 2650072
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat.
    Didlake RH; Kim EK; Sheehan K; Schreiber RD; Kahan BD
    Transplantation; 1988 Jan; 45(1):222-3. PubMed ID: 3122384
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased frequency of alloantigen-specific T cells following immunosuppression with extracted donor histocompatibility antigen and a brief course of cyclosporine.
    Ito T; Stepkowski SM; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):248-51. PubMed ID: 2650113
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of the timing of antigen administration on synergistic immunosuppression with cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Jul; 40(1):108-10. PubMed ID: 3892789
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of a combined regimen of cyclosporine and 3M KCl extracted histocompatibility antigen on heterotopic rat cardiac allograft survival.
    Didlake RH; Kim EK; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1034-7. PubMed ID: 2968693
    [No Abstract]   [Full Text] [Related]  

  • 11. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine induces reduction of antigen-specific T cytotoxic clones in rats transplanted with heart allografts.
    Miyagawa S; Lawen JG; Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):485-6. PubMed ID: 1990592
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of transplantation tolerance by perioperative injection of "quasi-self" chimeric class I MHC antigen combined with a short cyclosporine course.
    Ghobrial R; Hamashima T; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):239-40. PubMed ID: 7878984
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful orthotopic total bowel allotransplantation in the rat utilizing low-dose cyclosporine therapy.
    Shimazu R; Grogan JB; Raju S
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2877-8. PubMed ID: 2784917
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison between pancreas and heart allotransplantation after administration of donor-specific antigen and cyclosporine.
    Cooke JC; McBride JL; Schulak JA
    Transplantation; 1989 Jul; 48(1):15-9. PubMed ID: 2473549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 18. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.